Weekly Executive & Director Moves (Aug 25)

by | Aug 25, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

AIN, CAC, CGRN, FREY, GPS, GRPH, MWA, ZBH

CFO

ARQT, AXNX, DRTT, FIS, FOLD, GRPH, HAIN, HPE, KAMN, KNTK, KTB, LNW, MODV, MRTX, MWA, PRAA, PRTYQ, QTRX, UFI

Directors

AIN, ANIP, APRE, AUPH, BAX, BURU, CABO, CAC, CACI, CANO, CGRN, DLTH, EL, FICO, FITB, FMNB, FORG, FREY, FRG, GRPH, HAIN, HYZN, IMMX, KLIC, KODK, LOCO, LRCX, LVLU, MCD, MCHP, MWA, NNBR, ON, PYXS, QTRX, REEMF, SCPL, SCTL, SPCE, SPTN, SUPN, TEX, TYME, WT, XEL, ZBH

CEO Moves

ALBANY INTERNATIONAL CORP (AIN)
Leaving: CEO – Andrew William Higgins ( 3.7 yrs; 5.6% TSR)
Replaced by: Gunnar Kleveland

Prior to joining Albany International Corp., Mr. Kleveland, age 54, served in leadership positions in the business segments of Textron Inc. Most recently, he served as the President and Chief Executive Officer of Textron Specialized Vehicles Inc. Previously, Mr. Kleveland was the President of TRU Simulation + Trading Inc. Mr. Kleveland also held the position of Executive Vice President of Int…read full bio

CAPSTONE GREEN ENERGY CORP (CGRN)
Leaving: CEO – Darren Jamison ( 16.7 yrs; -29.5% TSR)
Replaced by: Robert C Flexon
 
Robert C. Flexon. Mr. Flexon has been a director since April 2018 and has served as Chair since January 2021. Mr. Flexon has served as a director of PG&E Corporation (NYSE:PCG) since June 2020 and as a director for Charah Solutions, Inc. (NYSE: CHRA) since June 2018. Mr. Flexon was President and Chief Executive Officer and Director of Dynegy Inc. (NYSE: DYN), a power generating company that owns a…read full bio

FREYR BATTERY (FREY)
Leaving: CEO – Tom Einar Jensen ( 2.0 yrs; -7.8% TSR)
Replaced by: Birger Steen
 
Mr. Steen, 56, is a technology investor based in Munich, Germany and has served since 2019 as Principal and then Thematic Partner at Summa Equity AB. He served as CEO of Parallels, Inc., a provider of cross-platform and virtual software solutions, from 2010 to 2016. He was Vice President of Worldwide SMB and Distribution at Microsoft Corp. (NASDAQ: MSFT) in Redmond and General Manager of Micr…read full bio

GRAPHITE BIO INC (GRPH)
Leaving: CEO – Joshua Lehrer-Graiwer ( 2.2 yrs; -65.3% TSR)
Replaced by: Kimberlee C Drapkin

Kim Drapkin has over 25 years of experience working with private and publicly traded biotechnology and pharmaceutical companies, including building and leading finance functions, raising capital, and leading strategic financial planning. Most recently, Ms. Drapkin was the CFO at Jounce Therapeutics, Inc., a position she held since the company’s inception, playing a key role in building Jo…read full bio

MUELLER WATER PRODUCTS INC (MWA)
Leaving: CEO – J Scott Hall ( 6.6 yrs; 2.8% TSR)
Replaced by: Marietta Edmunds Zakas

Marietta Edmunds Zakas has served as our Executive Vice President and Chief Financial Officer since January 2018. She served as Senior Vice President, Strategy, Corporate Development and Communications from November 2006 to December 2017. She was also the interim head of Human Resources from January 2016 to December 2017. Previously, Ms. Zakas held various positions at Russell Corporation, an athl…read full bio

ZIMMER BIOMET HOLDINGS INC (ZBH)
Leaving: CEO – Bryan C Hanson ( 5.7 yrs; 2.7% TSR)
Replaced by: Ivan Tornos

Mr. Tornos is not expected to be appointed to any committees of the Board. Mr. Tornos, age 48, has served as the Chief Operating Officer of the Company since March 2021. He previously served as the Company’s Group President, Global Businesses and the Americas beginning in December 2019 and, prior to that as Group President, Orthopedics since joining the Company in November 2018. Prior to joining t…read full bio

 

CFO Moves

AMICUS THERAPEUTICS INC (FOLD)
Leaving: CFO – Daphne Quimi ( 4.7 yrs; 4.2% TSR)
Replaced by: Simon Nr Harford

Mr. Harford does not have any family relationship with any executive officer or director of the Company, or with any person selected to become an officer or director of the Company. Neither Mr. Harford nor any member of his immediate family has any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Prior to joining the Compan…read full bio

ARCUTIS BIOTHERAPEUTICS INC (ARQT)
Leaving: CFO – Scott L Burrows ( 2.3 yrs; -39.4% TSR)
Replaced by: John W Smither

Mr. Smither, 70, served as the Company’s chief financial officer from May 2019 to March 2021. Prior to that, Mr. Smither served as chief financial officer of Sienna Biopharmaceuticals, Inc. from January 2016 to April 2017, and again from April 2018 to March 2019. From November 2017 to April 2018, he served as interim chief financial officer of Kite Pharma, Inc. during its integration with Gilead S…read full bio

DIRTT ENVIRONMENTAL SOLUTIONS LTD (DRTT)
Leaving: CFO – Bradley Little ( 1.0 yrs; -63.0% TSR)
Replaced by: Fareeha Khan

Ms. Khan, age 43, joined the Company in 2019 and has served in several key roles within the Company’s finance organization, including as Director – Internal Controls from May 2019 to March 2022, Financial Controller from April 2022 to May 2023 and Vice President of Finance since May 2023. Prior to joining the Company, Ms. Khan was a Senior Manager at PricewaterhouseCoopers LLP from …read full bio

GRAPHITE BIO INC (GRPH)
Leaving: CFO – Joshua Lehrer-Graiwer ( .2 yrs; )
Replaced by: Kimberlee C Drapkin

Kim Drapkin has over 25 years of experience working with private and publicly traded biotechnology and pharmaceutical companies, including building and leading finance functions, raising capital, and leading strategic financial planning. Most recently, Ms. Drapkin was the CFO at Jounce Therapeutics, Inc., a position she held since the company’s inception, playing a key role in building Jo…read full bio

HEWLETT PACKARD ENTERPRISE CO (HPE)
Leaving: CFO – Tarek Robbiati ( 4.9 yrs; 4.8% TSR)
Replaced by: Jeremy Cox

Mr. Cox will continue to serve as HPE’s Senior Vice President, Corporate Controller, Chief Tax Officer and Principal Accounting Officer. Mr. Cox, 46, has served as HPE’s Senior Vice President, Controller, Chief Tax Officer and Principal Accounting Officer since July 2022. Previously, he served as Senior Vice President, Global Tax and Head of Products and Services Finance from May 2021 to July 2022…read full bio

KAMAN CORP (KAMN)
Leaving: CFO – James Gordon Coogan ( 2.1 yrs; -31.1% TSR)
Replaced by: Carroll Kent Lane

Carroll K. Lane 47 Senior Vice President and Segment Lead, Engineered Products and Precision Products Mr. Lane joined the Company in July 2022 and was appointed segment lead of Precision Products as well as Senior Vice President and President, Kaman Air Vehicles and Kaman Precision Products. In January 2023, he was appointed segment lead of Engineered Products in addition to his previous responsib…read full bio

LIGHT & WONDER INC (LNW)
Leaving: CFO – Constance P James ( 1.8 yrs; -2.5% TSR)
Replaced by: Oliver Chow

Mr. Chow, age 43, has served as Senior Vice President of Corporate Finance since October 2022. Mr. Chow has more than 15 years of financial leadership experience across the entertainment and gaming industries. Prior to joining the Company, he spent five years in senior-level finance roles at Aristocrat, most recently serving as Chief Financial Officer — Americas, EMEA and Customer Ex…read full bio

MUELLER WATER PRODUCTS INC (MWA)
Leaving: CFO – Marietta Edmunds Zakas ( 5.6 yrs; 4.5% TSR)
Replaced by: Steven S Heinrichs

Mr. Heinrichs, 55, has served as Executive Vice President and Chief Legal and Compliance Officer and Corporate Secretary of the Company since 2018….read full bio

UNIFI INC (UFI)
Leaving: CFO – Craig A Creaturo ( 3.9 yrs; -20.7% TSR)
Replaced by: Andrew J. (“A.J.”) Eaker

Mr. Eaker, age 38, is a certified public accountant and has been Treasurer of the Company since December 2022 and a Vice President of the Company’s primary domestic operating subsidiary since June 2017.

read full bio

 

Director Joins

ALBANY INTERNATIONAL CORP (AIN)
Gunnar Kleveland
Prior to joining Albany International Corp., Mr. Kleveland, age 54, served in leadership positions in the business segments of Textron Inc. Most recently, he served as the President and Chief Executive Officer of Textron Specialized Vehicles Inc. Previously, Mr. Kleveland was the President of T…read full bio

 

ANI PHARMACEUTICALS INC (ANIP)

Matthew J Leonard

Mr. Leonard, 57, currently serves as Chief Pharmacy Strategy Officer of Capsule. Prior to this role, from April 2020 to May 2021, Mr. Leonard was an independent healthcare advisor, assisting numerous clients, including public and private companies, healthcare system provides, advisory and private eq…read full bio

AURINIA PHARMACEUTICALS INC (AUPH)
Jeffrey Allen Bailey

Jeffrey A. Bailey has significant pharmaceutical and biotech leadership experience, with expertise in supply chain, commercial, finance, business development, and product development. He has deep experience managing shareholder expectations and company objectives to achieve a successful outcome. …read full bio

 

AURINIA PHARMACEUTICALS INC (AUPH)
Karen L Smith
Dr. Karen Smith, MD, PhD, MBA, LLM, is a biotech and pharmaceutical executive, board director and clinical and scientific advisor. In addition to the growth and creation of R&D pipelines, Dr. Smith’s successful reco…read full bio

 

CABLE ONE INC (CABO)

P Robert Bartolo
Since May 2022, Mr. Bartolo has served as chair of the board of directors of Crown Castle Inc. (“Crown Castle”) and has served as a director of Crown Castle since February 2014. Mr. read full bio

FREYR BATTERY (FREY)
Birger Steen
Mr. Steen, 56, is a technology investor based in Munich, Germany and has served since 2019 as Principal and then Thematic Partner at Summa Equity AB. He served as CEO of Parallels, Inc., a provider of cross-platform and virtual software solutions, from 2010 to 2016. He was Vice President of Wor…read full bio

 

IMMIX BIOPHARMA INC (IMMX)

Yekaterina Chudnovsky

Ms. Chudnovsky has served as General Counsel for an international privately-held technology firm since 2009, overseeing intellectual property, trademarks, technology acquisition, and mergers & acquisitions. Ms. read full bio

MUELLER WATER PRODUCTS INC (MWA)
Marietta Edmunds Zakas

Marietta Edmunds Zakas has served as our Executive Vice President and Chief Financial Officer since January 2018. She served as Senior Vice President, Strategy, Corporate Development and Communications from November 2006 to December 2017. She was also the interim head of Human Resources from January…read full bio


QUANTERIX CORP (QTRX)
William P Donnelly

Mr. Donnelly brings many years of senior leadership experience in the life science tools industry, including 21 years at Mettler…read full bio



RARE ELEMENT RESOURCES LTD (REEMF)
Paul Joseph Hickey

Paul J. Hickey is a Wyoming attorney whose practice has focused on energy and natural resource issues. Mr. Hickey practiced law from 1975 until his reti…read full bio



ZIMMER BIOMET HOLDINGS INC (ZBH)
Ivan Tornos

Mr. Tornos is not expected to be appointed to any committees of the Board. Mr. Tornos, age 48, has served as the Chief Operating Officer of the Company since March 2021. He previously served as the Company’s Group President, Global Businesses and the Americas beginning in December 2019 and, prior to…read full bio



Director Exits

ANI PHARMACEUTICALS INC (ANIP)
David Nash ( 6.0 yrs; -.5% TSR)
Committees: Audit and Finance, Nominating (and Governance)

APREA THERAPEUTICS INC (APRE)
Christian S Schade ( 7.2 yrs; -71.4% TSR)

BAXTER INTERNATIONAL INC (BAX)
Michael F Mahoney ( 7.9 yrs; 3.8% TSR)
Committees: Compensation, Nominating (and Governance), Public Policy, Quality, Compliance and Technology, Special Litigation

CAMDEN NATIONAL CORP (CAC)
Gregory A Dufour ( 14.9 yrs; 8.3% TSR)
Committees: Capital Planning, Technology

CANO HEALTH INC (CANO)
Marlow Hernandez ( 2.2 yrs; -68.5% TSR)

CAPSTONE GREEN ENERGY CORP (CGRN)
Darren Jamison ( 16.7 yrs; -29.5% TSR)

EASTMAN KODAK CO (KODK)
Thomas Golisano B ( 2.3 yrs; -16.1% TSR)
Committees: Compensation, Compensation, Nominating and Governance, Nominating (and Governance)

EL POLLO LOCO HOLDINGS INC (LOCO)
John M Roth ( 16.6 yrs; -10.5% TSR)
Committees: Nominating (and Governance)

ESTEE LAUDER COMPANIES INC (EL)
Leonard A Lauder ( 65.6 yrs; 11.6% TSR)

FORGEROCK INC (FORG)
Alexander Ott ( 1.9 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
Bruce Golden ( 1.9 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
David S Welsh ( 1.9 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
Francis C Rosch ( 1.9 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
Jeffrey T Parks ( 3.3 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
Johanna Flower ( 1.9 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
Maria C Walker ( 1.9 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
Rinki Sethi ( 1.9 yrs; -30.3% TSR)

FORGEROCK INC (FORG)
Warren M Weiss ( 1.9 yrs; -30.3% TSR)

FRANCHISE GROUP INC (FRG)
Thomas Herskovits ( 7.8 yrs; 8.1% TSR)
Committees: Nominating (and Governance), Risk

FRANCHISE GROUP INC (FRG)
Cynthia S Dubin ( 2.3 yrs; -3.5% TSR)
Committees: Audit, Compensation, Risk

FRANCHISE GROUP INC (FRG)
Matthew E Avril ( 4.9 yrs; 28.4% TSR)
Committees: Audit, Compensation, Nominating (and Governance), Risk

FRANCHISE GROUP INC (FRG)
Gary S Rich ( 1.3 yrs; -14.0% TSR)

FRANCHISE GROUP INC (FRG)
Nanhi Singh ( 1.3 yrs; -14.0% TSR)
Committees: Audit

FRANCHISE GROUP INC (FRG)
Lisa M Fairfax ( 2.3 yrs; -3.5% TSR)
Committees: Nominating (and Governance)

GRAPHITE BIO INC (GRPH)
Joshua Lehrer-Graiwer ( 2.2 yrs; -65.3% TSR)

HYZON MOTORS INC (HYZN)
George Gu ( 2.1 yrs; -59.7% TSR)

MCDONALDS CORP (MCD)
Richard H Lenny ( 18.1 yrs; 16.1% TSR)
Committees: Audit & Finance, Compensation, Sustainability & Corporate Responsibility

MICROCHIP TECHNOLOGY INC (MCHP)
Esther Johnson ( 9.8 yrs; 18.1% TSR)
Committees: Audit, Compensation, Nominating (and Governance), Nominating, Governance, and Sustainability

MUELLER WATER PRODUCTS INC (MWA)
J Scott Hall ( 6.6 yrs; 2.8% TSR)
Committees: Executive

NN INC (NNBR)
Robert E Brunner ( 11.4 yrs; -9.8% TSR)
Committees: Compensation, Nominating (and Governance)

NN INC (NNBR)
Shihab A Kuran ( 2.4 yrs; -32.5% TSR)
Committees: Compensation, Nominating (and Governance)

SCIPLAY CORP (SCPL)
Constance P James ( 1.3 yrs; 43.2% TSR)
Committees: Strategy and Operations

TYME TECHNOLOGIES INC (TYME)
Paul L Sturman ( 6.5 yrs; -32.0% TSR)
Committees: Nominating (and Governance)

ZIMMER BIOMET HOLDINGS INC (ZBH)
Bryan C Hanson ( 6.6 yrs; 3.8% TSR)

Recent Analysis

Daily SPAC Update – June 14, 2024

PLMI Extension Vote. TETE Extends. COOL Sets Extension Vote. GPAC Investor Deck. BAYA, RCFA, GAMC Merger Agreements. COOL, RWOD, FLFV Update Trust Values.

Daily SPAC Update – June 13, 2024

Catcha Investment (CHAA) + Crown LNG Approved. DHAC + VSee Labs Deal Approved. SEDA Investor Deck. Feutune Light (FLFV) Updates Trust & Redemptions.

Daily SPAC Update – June 10, 2024

Bayview Acquisition Corp + Oabay Inc. SPAC deal announced. EVE extension vote today. BUJA sets extension vote. PWUP amends merger agreement. COOL postpones to June 26.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.